We are live on ! Find out more
VanEck Associates

VanEck Associates Portfolio holdings

AUM $133B
1-Year Est. Return 72.99%
This Fund
S&P 500
This Quarter Est. Return
+6.02%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$19.6B
AUM Growth
+$1.28B
Cap. Flow
+$411M
Cap. Flow %
2.1%
Top 10 Hldgs %
27.23%
Holding
759
New
28
Increased
391
Reduced
300
Closed
35

Sector Composition

Rank Sector Weight
1 Materials 51.83%
2 Energy 16.9%
3 Healthcare 8.12%
4 Technology 4.38%
5 Industrials 2.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MOS icon
201
The Mosaic Company
MOS
$7.09B
$15.2M 0.08%
704,296
-60,080
-8% -$1.3M
DO
202
DELISTED
Diamond Offshore Drilling
DO
$15M 0.08%
1,035,139
+73,721
+8% +$887K
RUN icon
203
Sunrun
RUN
$2.37B
$14.8M 0.08%
2,670,146
-24,039
-0.9% -$164K
VEDL
204
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
$14.5M 0.07%
748,230
+64,009
+9% +$1.18M
UTHR icon
205
United Therapeutics
UTHR
$26.3B
$14.4M 0.07%
123,100
+10,598
+9% +$1.35M
AMT.PRB
206
DELISTED
American Tower Corporation
AMT.PRB
$14.4M 0.07%
118,065
+13,398
+13% +$1.66M
NEE.PRR
207
DELISTED
NextEra Energy, Inc.
NEE.PRR
$14.2M 0.07%
257,599
+29,232
+13% +$1.61M
TEVA icon
208
Teva Pharmaceuticals
TEVA
$35.9B
$14.2M 0.07%
807,321
+370,380
+85% +$8.33M
NVS icon
209
Novartis
NVS
$295B
$14.1M 0.07%
182,835
-58,531
-24% -$4.42M
GPL
210
DELISTED
Great Panther Mining Limited
GPL
$14M 0.07%
1,129,671
+105,291
+10% +$1.36M
FSK icon
211
FS KKR Capital
FSK
$2.98B
$14M 0.07%
414,370
-3,641
-0.9% -$125K
EWT icon
212
iShares MSCI Taiwan ETF
EWT
$10B
$14M 0.07%
387,826
+272,592
+237% +$10M
GSK icon
213
GSK
GSK
$103B
$13.9M 0.07%
274,769
+25,289
+10% +$1.28M
OIS icon
214
Oil States International
OIS
$522M
$13.8M 0.07%
546,072
+83,781
+18% +$2.06M
SNY icon
215
Sanofi
SNY
$104B
$13.8M 0.07%
277,992
-5,729
-2% -$277K
NVO
216
Novo Nordisk
NVO
$216B
$13.8M 0.07%
574,346
-67,444
-11% -$1.52M
VALE icon
217
Vale
VALE
$62.9B
$13.7M 0.07%
1,363,708
+140,857
+12% +$1.42M
FMSA
218
DELISTED
Fairmount Santrol Holdings Inc.
FMSA
$13.7M 0.07%
2,864,113
-317,470
-10% -$1.03M
JNJ icon
219
Johnson & Johnson
JNJ
$635B
$13.7M 0.07%
105,144
-75,195
-42% -$9.97M
GORO icon
220
Goldgroup Mining Inc.
GORO
$151M
$13.3M 0.07%
3,558,299
+47,268
+1% +$184K
ALKS icon
221
Alkermes
ALKS
$8.82B
$13.3M 0.07%
261,551
-856
-0.3% -$45.8K
TTC icon
222
Toro Company
TTC
$8.93B
$13.2M 0.07%
211,897
-21,085
-9% -$1.41M
IONS icon
223
Ionis Pharmaceuticals
IONS
$9.35B
$13.1M 0.07%
257,705
+18,545
+8% +$971K
ON icon
224
ON Semiconductor
ON
$33.8B
$12.8M 0.07%
695,665
+286,909
+70% +$4.62M
TER icon
225
Teradyne
TER
$54.8B
$12.7M 0.06%
340,488
+149,914
+79% +$5.19M

Similar funds

VanEck Associates's Q3 2017 Portfolio in Review

As of Q3 2017, VanEck Associates held 759 positions worth $19.6B, up 7% from $18.3B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

VanEck Associates's Q3 2017 filing shows 28 new, 391 increased, 300 reduced and 35 closed positions. Its largest new stake was Kirkland Lake Gold Ltd Ordinary: 24,072,845 shares worth $310M. The largest sale was Silver Standard Resources, an estimated $127M.

By sector, the portfolio is most concentrated in Materials at 52% of assets, down from 54% a quarter earlier, followed by Energy and Healthcare.

  • VanEck Associates's largest Q3 2017 buy was Kirkland Lake Gold Ltd Ordinary: 24,072,845 shares worth $310M.
  • VanEck Associates added most to PRETIUM RESOURCES INC. in Q3 2017, an estimated $71.3M increase.
  • VanEck Associates's biggest Q3 2017 reduction was Barrick Mining, cutting an estimated $92.5M.
  • VanEck Associates fully exited Silver Standard Resources in Q3 2017, selling an estimated $127M.
  • VanEck Associates's ten largest holdings make up 27% of its $19.6B portfolio in Q3 2017.
  • VanEck Associates opened 28 new positions and closed 35 in Q3 2017.
  • VanEck Associates's portfolio value rose 7% quarter-over-quarter to $19.6B.

Based on VanEck Associates's 13F filing for Q3 2017, filed 9 Nov 2017.